Overview Rating

Speculative

Technicals Analysis

0100

Financials Analysis

0100

Alkermes (NASDAQ:ALKS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Alkermes (ALKS) operate in?

Alkermes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Alkermes Stock (NASDAQ: ALKS) stock price, news, charts, stock research, profile.

Open	$24.37
Close	$24.23
Volume / Avg.	508.31K / 1.87M
Day Range	24.12 - 24.54
52 Wk Range	22.01 - 32.88
Market Cap	$4.10B
P/E Ratio	7.20
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	10.32%
Days to Cover	6.16

Recent News

Orchestra BioMed Holdings, Inc. Stock Jumps 7.3%: Will It Continue to Soar?

Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) shares ended the last trading session 7.3% higher at $6.32. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 12.8% gain over the past four weeks.

Zacks

Alkermes' Sleeping Disorder Studies' Data Look Excellent, Analyst Says

ALKS 2680 reports positive results in narcolepsy & idiopathic hypersomnia study. Statistically significant improvements in sleep latency were observed across all doses tested. Phase 2 study for NT2 patients is planned for 2nd half of 2024. Jefferies raises price target & probability of success for ALKS-2680.

Vandana Singh

Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Alkermes plc

Sector

Health Care

Industry

Biotechnology

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies t...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Alkermes (ALKS) stock?

You can purchase shares of Alkermes (NASDAQ:ALKS) through any online brokerage.

View our list of the best stock brokerages

Who are Alkermes (ALKS) competitors?

Other companies in Alkermes’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE) and SpringWorks Therapeutics (NASDAQ:SWTX).

What is the target price for Alkermes (ALKS) stock?

There is no analysis for Alkermes.

What is the forecast for Alkermes (ALKS) stock?

Alkermes has a consensus price target of $32.47.

Current stock price for Alkermes (ALKS)?

The stock price for Alkermes (NASDAQ: ALKS) is $24.23 last updated Today at July 3, 2024 at 1:05 PM EDT.

Does Alkermes (ALKS) pay a dividend?

There are no upcoming dividends for Alkermes.

When is Alkermes (NASDAQ:ALKS) reporting earnings?

Alkermes’s Q2 earnings are confirmed for Wednesday, July 24, 2024.

Is Alkermes (ALKS) going to split?

There is no upcoming split for Alkermes.

What sector and industry does Alkermes (ALKS) operate in?

Alkermes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Alkermes

Alkermes (ALKS) Forecast